Dr. Grinspan's research program focuses on oligodendrocytes, cells of the central nervous system that synthesize the myelin sheath required for transmission of nervous impulses. Her research seeks to understand the signaling pathways that regulate oligodendrocyte maturation and how they are perturbed in diseases such as multiple sclerosis, HIV, and perinatal white matter injury.
For some patients, Children's Hospital of Philadelphia is more than just the place they visited for check-ups, MRI's, and medical tests: It's the spark of inspiration that encouraged them to study medicine, science, or research and kick-start a career in healthcare. As these students prepare to start college and secure financial aid this year, the Demyelinating Disease team in the
The Research Institute's commitment to cultivating and producing strong scientific research is grounded in the diverse mix of experiences, talents, and perspectives that our researchers contribute to our success.
"Diversity has long been a key driver of achievement at Children's Hospital of Philadelphia's Research Institute, particularly when it comes to innovation and performing more accurate and inclusive research," wrote Bryan
Some of the neurological and psychiatric complications associated with HIV may be side effects of the medications that control the virus, and not caused by the virus itself, according to a new study from researchers at The Children’s Hospital of Philadelphia and the University of Pennsylvania.
At a recent event in Cherry Hill, N.J., longtime CHOP researcher Judith Grinspan, PhD, received the "Professional Impact Award" from the Greater Delaware Valley Multiple Sclerosis Society. Dr. Grinspan has spent more than 25 years examining how multiple sclerosis damages the nervous system,